EKB Journal Management System


1.	Treatment and prognosis of Primary CNS lymphoma
	Pages 9-10
	Haitham M AbdelBary
	View Article PDF 621.91 K

2.	ALL Management Guideline
	Pages 11-14
	Rania A Radwan
	View Article PDF 854.8 K

3.	Perioperative Management of Anticoagulants and Antiplatelets
	Pages 15-17
	Haydi M Mohamed
	View Article PDF 1.5 M

4.	Diffuse large B -Cell Lymphoma ESMO Summary of recommendations
	Pages 18-20
	Mohamed A Shazly
	View Article PDF 959.23 K

5.	NCCN and ESMO guidelines For the diagnosis and management of AML
	Pages 21-23
	Nour Elhoda Hussein
	View Article PDF 801.54 K

6.	AASLD 2016 Recommendations for Testing, Managing, and Treating Hepatitis C
	Pages 24-27
	Rasha Kamel
	View Article PDF 838.38 K

7.	Capsule summary of NCCN Guidelines for Hodgkin Lymphoma
	Pages 28-31
	Mary Gamal
	View Article PDF 673.01 K

8.	Multiple Myeloma Guidelines adopted from NCCN and ESMO
	Pages 32-37
	Nahid Meowad
	View Article PDF 1.28 M

9.	Immunotherapy in ALL: from Bench to Bedside
	Pages 39-48
	Rania A Radwan
	View Article PDF 1.03 M

10.	Perioperative Management of Anticoagulants and Anti-Platelets
	Pages 49-59
	Haydi M Mohamed
	View Article PDF 1.16 M

11.	Chemotherapy-Induced Nausea and Vomiting (CINV)
	Pages 60-68
	Mohamed A Shazly
	View Article PDF 791.57 K

12.	Management of FLT-3 mutated AML
	Pages 69-75
	Nour Elhoda Hussein
	View Article PDF 667.96 K

13.	How I treat hepatitis C virus infection in patients with hematologic malignancies
	Pages 76-86
	Rasha Kamel
	View Article PDF 802.69 K

14.	Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
	Pages 87-95
	Mary Gamal
	View Article PDF 882.69 K

15.	The impact of microbiota on hematological disorders
	Pages 96-107
	Nahid Meowad
	View Article PDF 789.33 K